Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Transpl Infect Dis ; 25(6): e14179, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37910558

ABSTRACT

BACKGROUND: Viral infections such as adenovirus (ADV), BK virus (BKV), and cytomegalovirus (CMV) after kidney transplantation negatively impact outcomes in transplant recipients despite advancements in screening and antiviral therapy. We describe our experience of using the virus-specific T cell therapy (VSTs) in kidney transplant recipients (KTR) at our transplant center. METHODS: This is a retrospective, single center review of KTR with ADV, BKV and CMV infections between June 2021 and December 2022. These patients received third party VSTs as part of the management of infections. The immunosuppression, details of infection and outcome data were obtained from electronic medical records. RESULTS: Two cases of ADV infection resolved after one infusion of VSTs. The response rate of BKV and CMV infection was not as robust with close to 50% reduction in median viral load after VSTs. Out of 23 patients, two patients developed chronic allograft nephropathy from membranoproliferative glomerulonephritis and acute rejection. CONCLUSION: Patients that are resistant to antivirals or who have worsening viremia despite conventional management may benefit from VSTs therapy to treat underlying viral infection. Additional studies are needed to ascertain efficacy and short- and long-term risks secondary to VSTs.


Subject(s)
BK Virus , Cytomegalovirus Infections , Kidney Transplantation , Polyomavirus Infections , Tumor Virus Infections , Humans , Kidney Transplantation/adverse effects , Retrospective Studies , Transplant Recipients , Polyomavirus Infections/complications , Cytomegalovirus Infections/drug therapy , Cytomegalovirus Infections/complications , Cell- and Tissue-Based Therapy , BK Virus/physiology
2.
Ther Deliv ; 6(7): 855-71, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26228776

ABSTRACT

The natural biopolymer chitosan has versatile applications in therapeutic delivery. Coating drug delivery matrices or biomaterials with chitosan offers several advantages in drug delivery, including control of drug release, slowing degradation rate and improving biocompatibility. Advanced uses of chitosan in coating form include targeting drug delivery vehicles to specific tissue as well as providing a stimulus-controlled release response. The present review summarizes the current applications of chitosan coatings in the context of different biomaterial delivery technologies, as well as future directions of chitosan coatings for drug delivery technologies under development.


Subject(s)
Chitosan/chemistry , Drug Carriers/chemistry , Gene Transfer Techniques , Animals , Chemistry, Pharmaceutical , Coated Materials, Biocompatible , Delayed-Action Preparations , Drug Stability , Humans , Kinetics , Solubility , Technology, Pharmaceutical/methods
3.
Adv Mater ; 25(11): 1583-8, 2013 Mar 20.
Article in English | MEDLINE | ID: mdl-23335090

ABSTRACT

Multicolor electrophosphorescent organic light-emitting diode (OLED) pixel patterning by organic vapor jet printing (OVJP) is demonstrated, showing that this technique is capable of rapidly generating high-definition full-color displays. The resolution limits, and means to achieve them are described using a combination of simulation and experimental approaches.

4.
Anal Bioanal Chem ; 390(3): 847-55, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17624517

ABSTRACT

Efficient and robust particle separation and enrichment techniques are critical for a diverse range of lab-on-a-chip analytical devices including pathogen detection, sample preparation, high-throughput particle sorting, and biomedical diagnostics. Previously, using insulator-based dielectrophoresis (iDEP) in microfluidic glass devices, we demonstrated simultaneous particle separation and concentration of various biological organisms, polymer microbeads, and viruses. As an alternative to glass, we evaluate the performance of similar iDEP structures produced in polymer-based microfluidic devices. There are numerous processing and operational advantages that motivate our transition to polymers such as the availability of numerous innate chemical compositions for tailoring performance, mechanical robustness, economy of scale, and ease of thermoforming and mass manufacturing. The polymer chips we have evaluated are fabricated through an injection molding process of the commercially available cyclic olefin copolymer Zeonor 1060R. This publication is the first to demonstrate insulator-based dielectrophoretic biological particle differentiation in a polymeric device injection molded from a silicon master. The results demonstrate that the polymer devices achieve the same performance metrics as glass devices. We also demonstrate an effective means of enhancing performance of these microsystems in terms of system power demand through the use of a dynamic surface coating. We demonstrate that the commercially available nonionic block copolymer surfactant, Pluronic F127, has a strong interaction with the cyclic olefin copolymer at very low concentrations, positively impacting performance by decreasing the electric field necessary to achieve particle trapping by an order of magnitude. The presence of this dynamic surface coating, therefore, lowers the power required to operate such devices and minimizes Joule heating. The results of this study demonstrate that iDEP polymeric microfluidic devices with surfactant coatings provide an affordable engineering strategy for selective particle enrichment and sorting.


Subject(s)
Biocompatible Materials/chemistry , Electrophoresis, Microchip , Microfluidics , Polymers/chemistry , Bacillus subtilis/metabolism , Bacillus thuringiensis/metabolism , Electrochemistry/methods , Equipment Design , Hot Temperature , Kinetics , Microfluidic Analytical Techniques , Poloxamer/chemistry , Surface Properties , Surface-Active Agents , Tissue Engineering/methods
5.
Philos Trans A Math Phys Eng Sci ; 362(1818): 971-86, 2004 May 15.
Article in English | MEDLINE | ID: mdl-15306479

ABSTRACT

An analytical model is presented for the three-dimensional flow in the recently introduced staggered herringbone mixer for microchannels. In this model, the flow in the cross-section of the channel is treated as a lid-driven cavity flow. The model is shown to reproduce the advection patterns that were observed experimentally in the staggered herringbone mixer. The model is then used to study the quality of mixing in this flow as a function of geometry. Analysis is performed with Poincaré maps, mixing simulations, and residence time distributions. A range of optimal geometries is identified.


Subject(s)
Complex Mixtures/chemistry , Equipment Failure Analysis/methods , Microchemistry/instrumentation , Microfluidics/instrumentation , Models, Chemical , Nanotechnology/instrumentation , Computer Simulation , Computer-Aided Design , Equipment Design/methods , Motion , Solutions
SELECTION OF CITATIONS
SEARCH DETAIL
...